Thiazolidinediones are antihyperglycemic drugs used to treat diabetes that increase insulin sensitivity in adipose tissue, muscles and the liver to increase glucose use and decrease its production. They are known, however, to also affect bone. This Review examines the available data to assess the effect of these drugs on skeletal health.
- Allyson K McDonough
- Richard S Rosenthal
- Kenneth G Saag
